This report includes information about branchiootic syndrome 1 (BOS1), which is one of several related autosomal dominant diseases associated with the human gene EYA1; see the human disease model report for 'branchiootorenal spectrum disorders, EYA1-related' (see FBhh0000463).
Variant(s) implicated in human disease tested (as analogous mutation in fly gene): E528K in the fly eya gene [corresponds to E330K (E363K) in the human EYA1 gene; R715G in the fly eya gene [corresponds to R514G (R547G) in the human EYA1 gene]. It has been postulated that these two variants are associated with anterior segment anomalies manifesting in ocular disorders in humans, but supporting evidence is limited.
[updated Jul. 2017 by FlyBase; FBrf0222196]
[BRANCHIOOTIC SYNDROME 1; BOS1](https://omim.org/entry/602588)
[EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 1; EYA1](https://omim.org/entry/601653)
The phenotypic manifestations of branchiootorenal spectrum disorders are typically in the areas of the branchial arch, ear and kidney. For the implicated gene EYA1, some missense mutations may result in ocular defects (Azuma et al., 2000; pubmed:10655545).
Branchiootic syndrome (BOS) is characterized by sensorineural, conductive, or mixed hearing loss, structural defects of the outer, middle, and inner ear, and branchial fistulas or cysts; it is characterized by the same branchial and otic anomalies as those seen in individuals with the branchiootorenal syndrome (BOR1), but lacks renal anomalies (Vincent et al., 1997; pubmed:9359046). [from MIM:602588, MIM:113650; 2017.01.06]
Branchiootic syndrome 1 (BOS1) is caused by heterozygous mutation in the EYA1 gene (autosomal dominant). [from MIM:602588; 2017.01.06]
Many to one: 4 human to 1 Drosophila; the other human genes are EYA2, EYA3, and EYA4.
Moderate- to high-scoring ortholog of human EYA1, EYA2, EYA3, and EYA4 (1 Drosophila to 4 human). Dmel\eya shares 39-45% identity and 51-58% similarity with the human genes.